Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-PS23-001, Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP) and RFA-PS23-005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-Traditional Settings: Emergency Department; Amended Notice of Closed Meeting, 23428 [2023-07991]
Download as PDF
<![CDATA[
23428
Federal Register / Vol. 88, No. 73 / Monday, April 17, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
lotter on DSK11XQN23PROD with NOTICES1
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)— RFA–PS–23–
002, Enhancing Telehealth Strategies
To Support Retention and Adherence
to Antiretroviral Therapy (ART), and
RFA–PS–23–003, Exploring
Preferences for Long-Acting
Antiretroviral Therapies (LA–ART) in a
Community-Based Sample of Priority
Populations Living With HIV Who Are
Disproportionately Affected; Amended
Notice of Closed Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)— RFA–
PS23–002, Enhancing Telehealth
Strategies to Support Retention and
Adherence to Antiretroviral Therapy
(ART), and RFA–PS23–003, Exploring
Preferences for Long-Acting
Antiretroviral Therapies (LA–ART) in a
Community-Based Sample of Priority
Populations Living with HIV Who are
Disproportionately Affected; May 11–
12, 2023, 10 a.m.—5 p.m., EDT,
teleconference, Centers for Disease
Control and Prevention, 8 Corporate
Boulevard, Room 1077, Atlanta, Georgia
30329, in the original Federal Register
Notice. The meeting was published in
the Federal Register on March 8, 2023,
Volume 88, Number 45, page 14370.
The meeting is being amended to
remove RFA–PS23–002, Enhancing
Telehealth Strategies to Support
Retention and Adherence to
Antiretroviral Therapy (ART) and to
remove the second day of the meeting.
The notice should read as follows:
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–PS23–003, Exploring Preferences
for Long-Acting Antiretroviral Therapies
(LA–ART) in a Community-Based
Sample of Priority Populations Living
with HIV Who are Disproportionately
Affected.
Date: May 11, 2023.
Time: 10 a.m.–5 p.m., EDT.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329–4027. Telephone: (404)
718–8833; Email: GAnderson@cdc.gov.
VerDate Sep<11>2014
16:57 Apr 14, 2023
Jkt 259001
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–07996 Filed 4–14–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—RFA–PS23–
001, Increasing PrEP Use Among Black
Cisgender Women in the United States
(HerPrEP) and RFA–PS23–005,
Expanding Rapid Initiation of
Antiretroviral Therapy in NonTraditional Settings: Emergency
Department; Amended Notice of
Closed Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—RFA–
PS–23–001, Increasing PrEP Use Among
Black Cisgender Women in the United
States (HerPrEP), and RFA–PS–23–005,
Expanding Rapid Initiation of
Antiretroviral Therapy in Nontraditional Settings: Emergency
Department; May 24–25, 2023, 10 a.m.–
5 p.m. EDT, Teleconference, Centers for
Disease Control and Prevention, Room
1077, 8 Corporate Blvd., Atlanta, GA
30329 in the original Federal Register
Notice. The meeting was published in
the Federal Register on March 8, 2023,
Volume 88, Number 45, pages 14372–
14373.
The meeting is being amended to
remove the second day of the meeting.
The notice should read as follows:
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–PS–23–001, Increasing PrEP Use
Among Black Cisgender Women in the
United States (HerPrEP), and RFA–PS–
23–005, Expanding Rapid Initiation of
Antiretroviral Therapy in Nontraditional Settings: Emergency
Department.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Date: May 24, 2023.
Time: 10 a.m.–5 p.m., EDT.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329–4027. Telephone: (404)
718–8833; Email: GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–07991 Filed 4–14–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health, National Institute for
Occupational Safety and Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Advisory Board on Radiation and
Worker Health (ABRWH or the Advisory
Board). This meeting is open to the
public, but without a public comment
period. The public is welcome to submit
written comments in advance of the
meeting, to the contact person below.
Written comments received in advance
of the meeting will be included in the
official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the teleconference
(information below). The audio
conference line has 150 ports for callers.
DATES: The meeting will be held on June
14, 2023, from 11 a.m. to 1 p.m., EDT.
Written comments must be received on
or before June 7, 2023.
SUMMARY:
E:\FR\FM\17APN1.SGM
17APN1
]]>Agencies
[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Notices]
[Page 23428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07991]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP)--RFA-PS23-001, Increasing PrEP Use Among Black
Cisgender Women in the United States (HerPrEP) and RFA-PS23-005,
Expanding Rapid Initiation of Antiretroviral Therapy in Non-Traditional
Settings: Emergency Department; Amended Notice of Closed Meeting
Notice is hereby given of a change in the meeting of the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP)--RFA-PS-23-001, Increasing PrEP Use Among Black Cisgender Women
in the United States (HerPrEP), and RFA-PS-23-005, Expanding Rapid
Initiation of Antiretroviral Therapy in Non-traditional Settings:
Emergency Department; May 24-25, 2023, 10 a.m.-5 p.m. EDT,
Teleconference, Centers for Disease Control and Prevention, Room 1077,
8 Corporate Blvd., Atlanta, GA 30329 in the original Federal Register
Notice. The meeting was published in the Federal Register on March 8,
2023, Volume 88, Number 45, pages 14372-14373.
The meeting is being amended to remove the second day of the
meeting. The notice should read as follows:
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--RFA-PS-23-001, Increasing PrEP
Use Among Black Cisgender Women in the United States (HerPrEP), and
RFA-PS-23-005, Expanding Rapid Initiation of Antiretroviral Therapy in
Non-traditional Settings: Emergency Department.
Date: May 24, 2023.
Time: 10 a.m.-5 p.m., EDT.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop US8-1, Atlanta, Georgia 30329-4027.
Telephone: (404) 718-8833; Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-07991 Filed 4-14-23; 8:45 am]
BILLING CODE 4163-18-P
